Adenosine stimulates angiogenesis by up-regulating production of thrombospondin-1 by macrophages

Journal of Leukocyte Biology

Volumn 97, Issue 1, 2015, Pages 9-18

  Ernens, Isabelle ^a   Bonsquenaud, Mélanie ^a   Lenoir, Bénédicte ^a   Devaux, Yvan ^a   Wagner, Daniel R ^a,b  

^a Laboratoire d'Analyse Des Materiaux   (Luxembourg)

^b CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

Author keywords

Adenosine receptors; Aortic ring; Cardiac repair; Matrigel plug; Revascularization

Indexed keywords

ADENOSINE; ADENOSINE 2B RECEPTOR; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ANTIBODY; CHOLERA TOXIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; FORSKOLIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; THROMBOSPONDIN 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLS BY BODY ANATOMY; CONTROLLED STUDY; DOSE RESPONSE; EXPLANT; HEART INFARCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MALE; MICROVESSEL OUTGROWTH; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR RING; VASCULARIZATION; ANIMAL; BIOSYNTHESIS; CONFOCAL MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WISTAR RAT;

RATTUS;

ADENOSINE; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MACROPHAGES; MALE; MICROSCOPY, CONFOCAL; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; THROMBOSPONDIN 1; UP-REGULATION;

EID: 84925282989     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3HI0514-249RR     Document Type: Article

References (45)

1. Maulik. N. (2004) Angiogenic signal during cardiac repair. Mol. Cell Biochem. 264, 13-23.
2. Yoon, Y. S., Johnson, I. A., Park, J. S., Diaz, L, Losordo, D. W. (2004) Therapeutic myocardial angiogenesis with vascular endothelial growth factors. Mol Cell. Biochem. 264, 63-74.
3. Fukuda, S., Kaga, S., Sasaki, H., Zhan, I,., Zhu, I,., Otani, H., Kalfin, R., Das, D. K., Maulik, N. (2004) Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction. J. Mol. Cell Cardiol 36, 547-559.
4. McIntosh, V. J., Lasley, R. D. (2012) Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant? J. Cardìovasc. Pharmacol Ther. 17, 21-33.
5. Feoktistov, I., Biaggioni, I., Cronstein, B. N. (2009) Adenosine receptors in wound healing, fibrosis and angiogenesis. Handb. Exp. Pharmacol. 383-397.
6. Auchampach, J. A. (2007) Adenosine receptors and angiogenesis. Circ. Res. 101, 1075-1077.
7. Frangogiannis, N. G., Smith, C. W., Entman, M. L. (2002) The inflammatory response in myocardial infarction. Cardiovasc. Res. 53, 31-47.
8. Haskó, G., Pacher, P. (2012) Regulation of macrophage function by adenosine. Arterioscler. Thromb. Vase. Biol. 32, 865-869.
9. Hasko, G., Kuhel, D. G., Chen.J. F., Schwarzschild, M. A., Deitch, E. A., Mabley, J. G., Marton, A., Szabo, C. (2000) Adenosine inhibits IL-12 and TNF-alpha production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J. 14, 2065-2074.
10. Haskó, G, Pacher, P., Deitch, E. A., Vizi, E. S. (2007) Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol. Ther. 113, 264-275.
11. Nemeth, Z. H., Lutz, C. S., Csóka, B., Deitch, E. A., Leibovich, S.J., Cause, W. C., Tone, M., Pacher, P., Vizi, E. S., Haskó, G. (2005) Adenosine augments 11,-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism.J. Immunol. 175, 8260-8270.
12. Gessi, S., Fogli, F., Sacchetto, V., Merighi, S., Varani, K., Preti, D., Leung, F., Maclennan, S., Borea, P. A. (2010) Adenosine modulates HIF-1 lalphal, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells. Arterioscler. Thromb. Vase. Biol. 30, 90-97.
13. Ernens, I., Leonard, F., Vausort, M., Rolland-Turner, M., Devaux, Y., Wagner, D. R. (2010) Adenosine up-regulates vascular endothelial growth factor in human macrophages. Biochem. Biophys. Res. Commun. 392, 351-356.
14. Kreckler, I. M., Wan, T. C., Ge, Z. D., Auchampach, J. A. (2006) Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor. J. Pharmacol. Exp. Ther. 317, 172-180.
15. Bornstein, P. (2009) Thrombospondins function as regulators of angiogenesis. J. Cell Commun. Signal. 3, 189-200.
16. Jaffe, E. A., Ruggiero, J. T., Falcone, D. J. (1985) Monocytes and macrophages synthesize and secrete thrombospondin. Blood 65, 79-84.
17. Jimenez, B., Volpert, O. V., Crawford, S. E., Febbraio, M., Silverstein, R. L., Bouck, N. (2000) Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med. 6, 41-48.
18. Lawler, P. R., Uiwler, J. (2012) Molecular basis for the regulation of angiogenesis by thrombospondin-1 and-2. Cold Spring Harb. Perspect. Med. 2, a006627.
19. BenEzra, D., Griffin, B. W., Maftzir, G., Aharonov, O. (1993) Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide. Invest. Ophthalmol. Vis. Sci. 34, 3601-3608.
20. Nicosia, R. F., Tuszynski, G. P. (1994) Matrix-bound thrombospondin promotes angiogenesis in vitro. J. Cell Biol. 124, 183-193.
21. Flpek, G. O., Cokhan, G. A., Bozova, S. (2008) Thrombospondin-1 expression correlates with angiogenesis in experimental cirrhosis. World J. Gastroenterol. 14, 2213-2217.
22. Motegi, K., Harada, K., Pazouki, S., Baillie, R., Schor, A. M. (2002) Evidence of a bi-phasic effect of thrombospondin-1 on angiogenesis. Histochem. J. 34, 411-421.
23. Qian, X., Wang, T. N., Rothman, V. I,., Nicosia, R. F., Tuszynski, G. P, (1997) Thrombospondin-l modulates angiogenesis in vitro by up-regulauon of matrix metalloproteinase-9 in endothelial cells. Exp. Cell Res. 235, 403-4 12.
24. Chatila, K., Ren, G., Xia, Y., Huebener, P., Bujak, M., Frangogiannis, N. G. (2007) The role of die thrombospondins in healing myocardial infarcts. Cardiovasc. Hematol. Agents Med. Chem. 5, 21-27.
25. Schellings, M. W., van Almen, G. C., Sage, E. H., Heymans, S. (2009) Thrombospondins in die heart: potential functions in cardiac remodeling. J Cell Commun. Signal. 3, 201-213.
26. Mustonen, E., Ruskoaho, H., Rysă.J. (2013) Thrombospondins, potential drug targets for cardiovascular diseases. Basic Clin. Pharmacol. Toxicol. 112, 4-12.
27. Xia. Y., Dobaczewski, M., Gonzalez-Quesada, C. Chen, W., Biernacka, A., Li, N., Lee, D. W., Frangogiannis, N. C. (2011) Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism. Hypertension 58, 902-911.
28. Frangogiannis, N. G., Ren, G., Dewald, O., Zymek, P., Haudek, S., Koerting, A., Winkelmann, K., Michael, L. H., Lawler, |., Entman, M. L. (2005) Critical role of endogenous thrombospondin-l in preventing expansion of healing myocardial infarcts. Circulation 111, 2935-2942.
29. Blacher, S., Devy, L., Burbridge, M. F., Roland, G, Tucker, G., Noël, A., Foidart, J. M. (2001) Improved quantification of angiogenesis in the rat aortic ring assay. Angiogenesis 4, 133-142.
30. Bousquenaud, M., Maskali, F., Poussier, S., Zangrando, J., Marie, P. Y., Boudey, H., Fay, R., Karcher, G., Wagner, D. R., Devaux, Y. (2013) Cardioprotective effects of adenosine within the border and remote areas of myocardial infarction. EJNMMI lies. 3, 65.
31. Fredholm, B. B. (2010) Adenosine receptors as drug targets. Exp. Cell Res- 316, 1284-1288.
32. Frangogiannis, N. G. (2012) Regulation of the inflammatory response in cardiac repair. Circ. Res. 110, 159-173.
33. Dobaczewski, M., de Haan, J.J., Frangogiannis, N. G. (2012) The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium. J. Cardiovasc. Transl. Res. 5, 837-847.
34. Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Linden, J., Müller, C. E. (2011) International Union of Basic and Clinical Pharmacology. LXXXI' Nomenclature and classification of adenosine receptors-an update. Pharmacol. Rev. 63, 1-34.
35. Sezaki, S., Hirohata, S., Iwabu, A., Nakamura, K., Toeda, K., Miyoshi, T., Yamawaki, H., Demircan, K., Kusachi, S., Shiratori, Y., Ninomiya, Y. (2005) Thrombospondin-l is induced in rat myocardial infarction and its induction is accelerated by ischemia/reperfusion. Exp. Biol. Med. (Maywood) 230, 621-630.
36. Desai, A., Victor-Vega, C, Gadangi, S., Montesinos, M. C., Chu, C. C., Cronstein, B. N. (2005) Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. Mol. Pharmacol. 67, 1406-1413.
37. Bienes-Martinez, R., Ordonez, A., Feijoo-Cuaresma, M., Corral-Escariz, M., Mateo, G., Stenina, O., Jimenez, B., Calzada, M.J. (2012) Autocrine stimulation of clear-cell renal carcinoma cell migration in hypoxia via HIF-independent suppression of thrombospondin-l. Sci. Rep. 2, 788.
38. Osada-Oka, M., Ikeda, T., Akiba, S., Sato, T. (2008) Hypoxia stimulates the autocrine regulation of migration of vascular smooth muscle cells via HIF-lalpha-dependent expression of thrombospondin-l. J. Cell. Biochem- 104, 1918-1926.
39. Velot, F. Haas, B., Leonard, F., Ernens, I., Rolland-Turner, M., Schwartz, C, Iongrois, D., Devaux, Y., Wagner, D. R. (2008) Activation of the adenosine-A3 receptor stimulates matrix metalloproteinase-9 secretion by macrophages. Cardiovasc. Res. 80, 246-254.
40. Taraboletti, G., Roberts, D., Liotta, L. A., Giavazzi, R. (1990) Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J. Cell Biol. 111, 765-772.
41. Nesselroth, S. M., Willis, A. I., Fuse, S., Olson, E. T., Lawler, J., Sumpio, B. E., Gahtan, V. (2001) The Cterminal domain of thrombospondin-l induces vascular smooth muscle cell chemotaxis. J. Vase. Surg. 33, 595-600.
42. Belardinelli, R., Belardinelli, L., Shryock, J. C. (2001) Effects of dipyridamole on coronary collateralization and myocardial perfusion in patients with ischaemic cardiomyopathy. Eur. Heart J. 22, 1205-1213.
43. Lee, W. W., Marinelli, B., van der Laan, A. M., Sena, B. F., Gorbatov, R., Leuschner, F., Dutta, P., Iwamoto, Y., Ueno, T., Begieneman, M. P., Niessen, H. W., Pick, J. J., Vinegoni, C., Pittet, M. J., Swirski, F. K., Tawakol, A., Di Carli, M., Weissleder, R., Nahrendorf, M. (2012) PET/ MR1 of inflammation in myocardial infarction. J. Ant Coll. Cardiol. 59, 153-163.
44. Ruiz-García, A., Monsalve, E., Novellasdemunt, L., Navarro-Sabaté, A., Manzano, A., Rivero, S., Castrillo, A., Casado, M., Laborda, J., Bartrons, R., Díaz-Guerra, M. J. (2011) Cooperation of adenosine with macrophage Toll-4 receptor agonists leads to increased glycolytic flux through the enhanced expression of PFKFB3 gene. J. Biol. Chem. 286, 19247-19258.
45. Gũndüz, D., Aslam, M., Krieger, U., Becker, L., Grebe, M., Arshad, M., Sedding, D. G., Härtel, F. V., Abdallah, Y., Piper, H. M., Voss, R. R., Noll, T. (2012) Opposing effects of ATP and adenosine on barrier function of rat coronary microvasculature. J. Mol. Cell. Cardiol. 52, 962-970.